SP
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ·Healthcare·Biotechnology
$5.78
+2.03%
Mkt Cap $595.82M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$25.50
Range $25.00 – $26.00
Implied Upside
+341.6%
Consensus $25.50 vs current $5.78
NASDAQ·Healthcare·Biotechnology
$5.78
+2.03%
Mkt Cap $595.82M
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$25.50
Range $25.00 – $26.00
+341.6%
Consensus $25.50 vs current $5.78